Dr. Michael Ingram, MD

NPI: 1295767283
Total Payments
$342,707
2024 Payments
$43,678
Companies
32
Transactions
836
Medicare Patients
30
Medicare Billing
$231.95

Payment Breakdown by Category

Other$264,808 (77.3%)
Travel$40,459 (11.8%)
Food & Beverage$18,902 (5.5%)
Consulting$18,244 (5.3%)
Education$233.88 (0.1%)
Gifts$58.79 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $264,808 153 77.3%
Travel and Lodging $40,459 94 11.8%
Food and Beverage $18,902 558 5.5%
Consulting Fee $18,244 7 5.3%
Education $233.88 20 0.1%
Gift $58.79 4 0.0%

Top Paying Companies

Company Total Records Latest Year
Alkermes, Inc. $111,397 181 $0 (2024)
Janssen Pharmaceuticals, Inc $77,356 136 $0 (2024)
Otsuka America Pharmaceutical, Inc. $62,787 160 $0 (2024)
Teva Pharmaceuticals USA, Inc. $57,641 104 $0 (2023)
Allergan Inc. $17,127 55 $0 (2018)
Otsuka Pharmaceutical Development & Commercialization, Inc. $6,407 10 $0 (2024)
ITI, Inc. $4,844 11 $0 (2022)
Sunovion Pharmaceuticals Inc. $2,431 32 $0 (2021)
Lundbeck LLC $562.63 42 $0 (2024)
Validus Pharmaceuticals LLC $419.33 8 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $43,678 58 Janssen Pharmaceuticals, Inc ($36,854)
2023 $17,684 52 Alkermes, Inc. ($9,460)
2022 $44,473 82 Alkermes, Inc. ($24,578)
2021 $28,846 44 Alkermes, Inc. ($18,372)
2020 $26,805 48 Alkermes, Inc. ($13,186)
2019 $56,416 138 Otsuka America Pharmaceutical, Inc. ($26,705)
2018 $82,729 244 Teva Pharmaceuticals USA, Inc. ($31,190)
2017 $42,076 170 Alkermes, Inc. ($18,933)

All Payment Transactions

836 individual payment records from CMS Open Payments — Page 1 of 34

Date Company Product Nature Form Amount Type
12/05/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $15.67 General
Category: PSYCHIATRY
12/04/2024 Alkermes, Inc. VIVITROL (Drug) Food and Beverage In-kind items and services $27.07 General
Category: CNS
11/26/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $20.54 General
Category: PSYCHIATRY
11/20/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging Cash or cash equivalent $128.00 General
Category: Neuroscience
11/20/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage Cash or cash equivalent $24.85 General
Category: Neuroscience
11/19/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $900.00 General
Category: Neuroscience
11/04/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,150.00 General
Category: Neuroscience
10/31/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging In-kind items and services $1,143.33 General
Category: Neuroscience
10/30/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $117.19 General
Category: Neuroscience
10/30/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $18.68 General
Category: Neuropsychiatry
10/29/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $11,760.00 General
Category: Neuroscience
10/23/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $116.06 General
Category: Neuroscience
10/19/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $59.41 General
Category: Neuroscience
10/19/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $58.92 General
Category: Neuroscience
10/19/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $40.00 General
Category: Neuroscience
10/18/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging In-kind items and services $1,085.59 General
Category: Neuroscience
10/18/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging In-kind items and services $444.58 General
Category: Neuroscience
10/18/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $147.58 General
Category: Neuroscience
10/11/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $14.31 General
Category: PSYCHIATRY
10/08/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging In-kind items and services $5.50 General
Category: Neuroscience
09/18/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $15.44 General
Category: Psychology/Psychiatric
09/16/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging Cash or cash equivalent $147.40 General
Category: Neuroscience
09/16/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Travel and Lodging Cash or cash equivalent $35.00 General
Category: Neuroscience
09/09/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. ABILIFY ASIMTUFII (Drug) Consulting Fee Cash or cash equivalent $4,374.00 General
Category: PSYCHIATRY
08/27/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,150.00 General
Category: Neuroscience

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2020 1 30 71 $2,966 $231.95
Total Patients
30
Total Services
71
Medicare Billing
$231.95
Procedure Codes
1

All Medicare Procedures & Services

1 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2020 30 71 $2,966 $231.95 7.8%

About Dr. Michael Ingram, MD

Dr. Michael Ingram, MD is a Psychiatry healthcare provider based in Bay City, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295767283.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ingram, MD has received a total of $342,707 in payments from pharmaceutical and medical device companies, with $43,678 received in 2024. These payments were reported across 836 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($264,808).

As a Medicare-enrolled provider, Ingram has provided services to 30 Medicare beneficiaries, totaling 71 services with total Medicare billing of $231.95. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Bay City, MI
  • Active Since 07/07/2006
  • Last Updated 04/12/2021
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1295767283

Products in Payments

  • INVEGA SUSTENNA (Drug) $67,522
  • AUSTEDO (Drug) $55,079
  • ARISTADA (Drug) $50,862
  • Aristada 441 mg (Drug) $38,135
  • REXULTI (Drug) $33,832
  • ABILIFY MAINTENA (Drug) $30,462
  • LYBALVI (Drug) $22,113
  • VRAYLAR (Drug) $17,320
  • SPRAVATO (Drug) $9,731
  • ABILIFY ASIMTUFII (Drug) $5,184
  • CAPLYTA (Drug) $4,864
  • LATUDA (Drug) $2,431
  • Austedo XR (Drug) $1,005
  • UZEDY (Drug) $840.00
  • SD809-TD (Drug) $562.95
  • Equetro (Drug) $419.33
  • NUPLAZID (Drug) $316.12
  • Vivitrol 380 mg (Drug) $231.60
  • INGREZZA (Drug) $188.99
  • TRINTELLIX (Drug) $152.60

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Bay City